Prostate-specific antigen: Insufficient discrimination between benign prostatic hyperplasia and organ-confined prostate cancer

Urologia Internationalis

Volumn 57, Issue 3, 1996, Pages 170-174

  Wolff, Johannes M ^a   Boeckmann, W ^a   Borchers, H ^a   St Handt, S ^a   Reineke, T ^a   Jakse, G ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Benign prostatic hyperplasia; Cancer of the prostate; Prostate specific antigen; Treatment modalities

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY;

EID: 0029799687     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000282904     Document Type: Article

References (40)

1. Hara M, Inorre T, Fukuyama T: Some physicochemical characteristics of gamma-scminopro-tcin. an antigenic component specific for human seminal plasma. Nippon Hoigaku Zasshi 1971:25:322.
2. Wang MC, Valenzuela LA, Murphy GP, Chu TM: Purification of a human prostate-specific antigen. Invest Urol 1979:17:159-163.
3. Riegman PH, Vlietstra RJ, Klassen P, van der Korput JAGM, Geurts van Kessel A, Romijn JC, Trapman J: The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 9. FEBS Lett 1989;247:123-126.
4. Brawer MK, Lange PH: Prostate specific antigen: Its role in early detection, staging and monitoring of prostatic carcinoma. J Endourol 1989:3:227-236.
5. Oesterling JE: Prostate specific antigen: A critical assessment of the most useful tumour marker for adenocarcinoma of the prostate. J Urol 1991:145:907-923.
6. Staemy TA, Vang N, Hay AR, McNeal JE, Freiha FS, Redwine E: Prostate specific antigen as a scrum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-916.
7. Lange PH, Ercolc CJ, Lightner DJ, Fraley EE. Vcssella R: The value of scrum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989:141:873-879.
8. Hudson MA, Bahnson RR, Catalona WJ: Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989; 142:1011-1017.
9. Berry SJ, Coffey DS. Walsh T: The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-479.
10. Carter HB, Coffey DS: The prostate: An increasing medical problem. Prostate 1990:16: 39-48.
11. Holund B: Latent prostatic cancer in a consecutive autopsy scries. Scand J Urol Nephrol 1980; 14:29-35.
12. Jensen OM, Esteve J, Moller H, Renard H: Cancer in the European Community and its member states. Eur J Cancer 1990:26:1167-1256.
13. Murphy GP, Natarajan N, Pontes JE, Schmitz RL, Smart CR, Schmidt JD, Mettlin C: The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol 1982:127:928-934.
14. Cooncr WH, Mosley BR, Rutherford CL Jr, Beard JH. Pond HS. Terry WJ. Igel TC. Kidd DD: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990;143:1146-1154.
15. Mettlin C, Lee F, Drago J, Murphy GP: American Cancer Society - National Prostate Cancer Detection Project: Findings on the detection of early prostate cancer in 2425 men. Cancer 1991:67:2949-2958.
16. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Cojen DE, Yuan JJ, Petros JA, Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-1161.
17. Brawer MH, Beatie J, Werner MH, Vessella RL, Preston SD, Lange PH: Screening for prostatic carcinoma with prostate specific antigen: Results of the second year. J Urol 1993:150: 106-109.
18. Catalona WJ, Smith DS, Ratliff TL, Basler JW: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993;270:948-954.
19. Catalona WJ, Richie JP, Ahmann F, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men. J Urol 1994:151: 1283-1290.
20. Sheldon Ca, Williams RD, Fraley EE: Incidental carcinoma of the prostate: A review of the literature and critical reappraisal of classification. J Urol 1980:124:626-631.
21. Cantrell BB, DeKlerk DP, Eggleston JC, Boit-nott JK, Walsh PC: Pathological factors that influence prognosis in stage A prostatic cancer: The influence of extent versus grade. J Urol 1981;125:516-520.
22. Braser MK, Rennels MA, Schiffman RA, Jounes JA: Serum prostate specific antigen and prostate pathology in men having simple prostatectomy. Am J Clin Pathol 1989:92:760-764.
23. Ercolc CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vessella RL: Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostate cancer. J Urol 1987:38:1181-1184.
24. Ferro MA, Barnes I, Roberts JBM, Smith PJB: Tumor markers in prostate cancer: A comparison of prostate specific antigen with acid phosphatase. Br J Urol 1987;60:69-73.
25. Allhoff E, de Ricse W, Eifinger M: Prostate specific antigen - Comparative clinical appreciation of a sérodiagnostic measure after 8 years of experience. World J Urol 1989;7:12-26.
26. Sershorn PD, Barry MJ, Osterling JE: Scrum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer. Eur Urol 1994;25:281-287.
27. Wolff JM, Boeckmann W, Effert PJ, Handt S, Jakse G: Evaluation of patients with diseases of the prostate using prostate-specific antigen density. Br J Urol 1995;76:41-46.
28. Rana A, Karamanis K, Lucal MG, Chisholm GD: Identification of metastatic disease by T category. Gleason score and serum PSA level in patients with carcinoma of the prostate. Br J Urol 1992:69:277-281.
29. Stamey TA, Freiha FS, McNeal JE, Redwine EA: Localized prostate cancer. Cancer 1993; 71:933-938.
30. Seaman E, Whang M, Olsson CA, Katz A, Cooner WH, Benson MC: PSA density: Role in patient evaluation and management. Urol Clin N Am 1993:20:4-653-4-664.
31. Benson MC, Olsson CA: Prostate specific antigen and prostate specific antigen density. Cancer 1994;15:1667-1673.
32. Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL, Rosner W, Walsh PC: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992;267:2215-2220.
33. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 1993;270:860-864.
34. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratlif TTL, Nadler RB: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995;274:1240-1220.
35. Wolff JM, Borchers H, Effert PJ, Habib FK, Jakse G: Frec-to-total prostate specific antigen concentrations in patients with prostate cancer and bcr.ign prostatic hyperplasia. Br J Urol, in press.
36. Catalona W, Hudson M, Scardino PT, Richie JP, Ahmann FR, Flanigan RC, De Kemion JB, Ratliff TL, Kavoussi LR: Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: Receiver operating characteristic curves. J Urol 1994:152:2037-2042.
37. Bangrna CH, Kranse R, Blijenberg BG, Schröder FH: The value of screening tests in the detection of prostate cancer. I. Results of a retrospective evaluation of 1726 men. Urology 1995:46:773-778.
38. Bangrna CH, Kranse R, Blijenberg BG, Schröder FH: The value of screening tests in the detection of prostate cancer. II. Retrospective analysis of free/total prostate-specific analysis ratio, age-specific ranges and PSA density. Urology 1995;46:779-784.
39. Paul R, Breul J, Hartung R: Prostate-specific antigen density and age-specific prostate-specific antigen values: The solution of prostate cancer screening? Eur Urol 1995:27:286-291.
40. Vallancien G, Prapotnich D, Veillon B, Brisset JM, Andre-Bougaran J, Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 1991; 146:1308-1312.